Literature DB >> 30020023

Characteristics of 1555 childhood-onset lupus in three groups based on distinct time intervals to disease diagnosis: a Brazilian multicenter study.

G V Novak1, B C Molinari1, J C Ferreira1, A P Sakamoto2, M T Terreri2, R M R Pereira3, C Saad-Magalhães4, N E Aikawa1,3, L M Campos1, C A Len2, S Appenzeller5, V P Ferriani6, M F Silva7, S K Oliveira8, A G Islabão9, F R Sztajnbok10, L B Paim11, C M Barbosa12, M C Santos13, B E Bica14, E G Sena15, A J Moraes16, A M Rolim17, P F Spelling18, I M Scheibel19, A S Cavalcanti20, E N Matos21, T C Robazzi22, L J Guimarães23, F P Santos24, C T Silva25, E Bonfá3, C A Silva1,3.   

Abstract

Objective The objective of this study was to compare demographic data, clinical/laboratorial features and disease activity at diagnosis in three different groups with distinct time intervals between onset of signs/symptoms and disease diagnosis. Methods A multicenter study was performed in 1555 childhood-onset systemic lupus erythematosus (American College of Rheumatology criteria) patients from 27 pediatric rheumatology services. Patients were divided into three childhood-onset systemic lupus erythematosus groups: A: short time interval to diagnosis (<1 month); B: intermediate time interval (≥1 and <3 months); and C: long time interval (≥3 months). An investigator meeting was held to define the protocol. Demographic data, SLICC classification criteria and SLEDAI-2 K were evaluated. Results The number of patients in each group was: A = 60 (4%); B = 522 (33.5%); and C = 973 (62.5%). The median age at diagnosis (11.1 (4.2-17) vs. 12 (1.9-17.7) vs. 12.5 (3-18) years, P = 0.025) was significantly lower in group A compared with groups B and C. The median number of diagnostic criteria according to SLICC (7 (4-12) vs. 6 (4-13) vs. 6 (4-12), P < 0.0001) and SLEDAI-2 K (18 (6-57) vs. 16 (2-63) vs. 13 (1-49), P < 0.0001) were significantly higher in group A than the other two groups. The frequency of oral ulcers in the palate (25% vs. 15% vs. 11%, P = 0.003), pleuritis (25% vs. 24% vs. 14%, P < 0.0001), nephritis (52% vs. 47% vs. 40%, P = 0.009), neuropsychiatric manifestations (22% vs. 13% vs. 10%, P = 0.008), thrombocytopenia (32% vs. 18% vs. 19%, P = 0.037), leucopenia/lymphopenia (65% vs. 46% vs. 40%, P < 0.0001) and anti-dsDNA antibodies (79% vs. 66% vs. 61%, P = 0.01) were significantly higher in group A compared with the other groups. In contrast, group C had a less severe disease characterized by higher frequencies of synovitis (61% vs. 66% vs. 71%, P = 0.032) and lower frequencies of serositis (37% vs. 33% vs. 25%, P = 0.002), proteinuria >500 mg/day (48% vs. 45% vs. 36%, P = 0.002) and low complement levels (81% vs. 81% vs. 71%, P < 0.0001) compared with groups A or B. Conclusions Our large Brazilian multicenter study demonstrated that for most childhood-onset systemic lupus erythematosus patients, diagnosis is delayed probably due to mild disease onset. Conversely, the minority has a very short time interval to diagnosis and a presentation with a more severe and active multisystemic condition.

Entities:  

Keywords:  Childhood-onset systemic lupus erythematosus; diagnosis; disease damage and disease activity

Mesh:

Substances:

Year:  2018        PMID: 30020023     DOI: 10.1177/0961203318787037

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  5 in total

Review 1.  Advances in rheumatology practice in Brazil.

Authors:  Francisco Airton Castro Rocha; Joaquim Ivo Vasques Dantas Landim; Leila Nascimento da Rocha
Journal:  Rheumatol Int       Date:  2018-12-01       Impact factor: 2.631

2.  Disease presentation of 1312 childhood-onset systemic lupus erythematosus: influence of ethnicity.

Authors:  Fernanda J Fiorot; Aline G Islabão; Rosa M Pereira; Maria T Terreri; Claudia Saad-Magalhães; Glaucia V Novak; Beatriz C Molinari; Ana P Sakamoto; Nadia E Aikawa; Lucia M Campos; Octavio A Peracchi; Simone Appenzeller; Virgínia P Ferriani; Marco F Silva; Adriana R Fonseca; Flávio R Sztajnbok; Luciana B Paim; Melissa M Fraga; Eunice M Okuda; Blanca E Bica; Evaldo G Sena; Ana J Moraes; Ana M Rolim; Paulo F Spelling; Iloite M Scheibel; André S Cavalcanti; Erica N Matos; Teresa C Robazzi; Luciano J Guimarães; Flávia P Santos; Valeria C Ramos; Magda Carneiro-Sampaio; Eloisa Bonfá; Clovis A Silva
Journal:  Clin Rheumatol       Date:  2019-06-13       Impact factor: 2.980

Review 3.  Diagnostic Delays and Psychosocial Outcomes of Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Afshan Hussain; Marvi V Maheshwari; Nabeeha Khalid; Pragnesh D Patel; Rahmah Alghareeb
Journal:  Cureus       Date:  2022-06-23

Review 4.  Oral Manifestations of Systemic Lupus Erythematosus: A Systematic Review.

Authors:  Paula García-Ríos; María Pilar Pecci-Lloret; Ricardo Elías Oñate-Sánchez
Journal:  Int J Environ Res Public Health       Date:  2022-09-21       Impact factor: 4.614

5.  An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Vitor Cavalcanti Trindade; Magda Carneiro-Sampaio; Eloisa Bonfa; Clovis Artur Silva
Journal:  Paediatr Drugs       Date:  2021-07-10       Impact factor: 3.022

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.